EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Heredo-Familial and Pediatric GISTs: Spot the Differences

Perez Alessandro

Scientific Journal of Genetics and Gene Therapy · 2019

DOI: 10.17352/sjggt.000007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Journal of Genetics and Gene Therapy, 2019. Verfasst von Perez Alessandro. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal stromal tumors (GISTs) are rare sporadic tumors that typically occur late in life, although they are the most common mesenchymal neoplasms of the gastrointestinal tract.GISTs are believed to originate from the Interstitial Cells of Cajal (ICC), a group of cells identified in the wall of the organs of the gastrointestinal tract, which act as a pace-maker for peristalsis and gut movements.However, familial and pediatric cases have also been reported.These rare subsets of GISTs have clinicopathological and molecular features different from their sporadic counterparts.Pediatric GISTs account for only 1% of all the identified cases of GISTs.Most of them lack the gain-of-function mutation in c-KIT or PDGFRA commonly found in adult cases, and may harbor mutations in other genes such as SDH.Gene expression profiling studies of pediatric GISTs show distinct molecular signatures, suggesting a unique origin as compared with adult GISTs.The review discusses also familial GISTs with germline c-KIT or PDGFRA gene mutations and variants harbouring no mutations in these genes such as Carney triad, Carney-Stratakis syndrome, and neurofibromatosis type 1.However, the initial phases of familial GISTs appear biologically similar to those of sporadic GISTs, with similar cytogenetic progression mechanisms and genic expression profiles. Biomolecular features of GISTs: c-KIT and PDGFRAMolecular genetics has not only revealed the mechanism involved in the genesis of GIST but, also, gave us an immunophenotypic marker, the c-KIT protein [12].The majority of GISTs (90-95%) show activating mutations of c-KIT with KIT/CD117 immunopositivity of approximately 95%.This marker allows then to deliver a very reliable diagnosis in 90-95% of cases [13,14].c-KIT is an oncogene mapping on chromosome 4q12 and is composed of 21 coding exons [15].The codifying sequence presents 4 mutational "hot spot" falling, in frequency order, in exons 11, 9, 13 and 17 [16].KIT is a 145KD transmembrane glycoprotein with tyrosine kinase activity, a pivotal enzyme involved in development (differentiation) and cell growth (proliferation) [17].In non-pathological conditions c-KIT is a receptor with TK activity that acts s a "cellular switch".Indeed, if activated from the interaction of its ligand (stem cell factor, SCF) with the extracellular portion of the receptor via dimerization, triggers the activation of an intracellular pathway that initiates a cascade of signals whose final aim is to increase proliferation, differentiation and inhibition of apoptosis [18].More in detail, the binding of a SCF molecule with each of the c-KIT monomers gives rise to the

Zitieren

APA

Alessandro, P. (2019). Heredo-Familial and Pediatric GISTs: Spot the Differences. Scientific Journal of Genetics and Gene Therapy. https://doi.org/10.17352/sjggt.000007

Vancouver

Alessandro P. Heredo-Familial and Pediatric GISTs: Spot the Differences. Scientific Journal of Genetics and Gene Therapy. 2019. doi:10.17352/sjggt.000007

BibTeX
@article{Alessandro2019,
  author = {Alessandro, Perez},
  title = {Heredo-Familial and Pediatric GISTs: Spot the Differences},
  journal = {Scientific Journal of Genetics and Gene Therapy},
  year = {2019},
  doi = {10.17352/sjggt.000007}
}
Kostenlos starten →